Compass Therapeutics at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Compass Therapeutics at ESMO 2026 in Madrid: Booth 8114.

OrganizationESMO 2026 Attendance
compasstherapeutics.com
BiotechExhibitor
Clinical-stage biotech developing tovecimig, a DLL4/VEGF-A bispecific antibody, for biliary tract cancer.
Booth
Exhibiting at Booth 8114

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Compass Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction